We are working towards the eradication of Malaria, starting from the development of a novel mRNA vaccine, and the intend to manufacture it end-to-end in Africa .
BioNTech SE, co-developer of the first mRNA-based COVID-19 vaccine, aims to create a safe and highly effective mRNA vaccine with durable protective immunity for prevention of malaria and disease-associated mortality.
The company’s project is the first project of eradicateMalaria, a programme by the kENUP Foundation to accelerating the eradication of Malaria in close cooperation with the World Health Organization (WHO), supported by the European Commission, the European Investment Bank (EIB) and the Bill & Melinda Gates Foundation.